Hogan Lovells has advised PerkinElmer on the deal.
PerkinElmer made an all cash, public takeover offer for Horizon Discovery Group PLC, a leading gene editing company. The deal has a total enterprise value of approximately $368 million (£284 million) and is expected to close in the first quarter of 2021 subject to customary closing conditions.
Among other benefits, the acquisition will enable PerkinElmer to leverage its combined screening and applied genomics solutions to help propel the next phase of cell and gene research for precision medicine.
The Hogan Lovells team was led by Corporate M&A partner Tom Brassington (Picture) with support from counsel Karla Dudek.
Law Firms: Hogan Lovells;
Clients: PerkinElmer Inc.;